Australia Plans Changes To GMP Fee Structure To Help Cover Costs
Executive Summary
Australia is planning changes to the way it charges pharmaceutical manufacturers for activities related to good manufacturing practice, such as inspections, because the current arrangements do not allow it to recover its costs.
You may also be interested in...
Australia's Revised GMP Fee To Apply From 1 July
Under Australia's new fee model for good manufacturing practice inspections, domestic manufacturers will no longer be able to accrue unbillable “free inspection hours.” Any residual free hours will expire on July 1, 2020.
Pharma Firms Alarmed By Australian Plans To Raise GMP Fees
Medicines Australia says that none of the options for recovering GMP costs set out in its consultation earlier this year are suitable, although views among individual pharmaceutical companies differ.
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.